test

Zhanping Wu

@Vivo Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$1.208BTotal holdings43
Assets growth rate11.63%Assets growth rate (2-Q avg)-1.65%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Vivo Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 43 positions.

Assets under management

The assets under management (AUM) of Vivo Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.208B in assets, with a quarterly growth rate of 11.63% and a 2-quarter average growth rate of -1.65%. The portfolio is managed by Zhanping Wu, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SLNOSoleno Therapeutics Inc
Recent Activity
Decreased -14%
26.3%
$317.676M
6.292M shares@ $50.5 avg price
GERNGeron Corp
Recent Activity
10.23%
$123.603M
27.225M shares@ $4.55 avg price
HRMYHarmony Biosciences Holdings Inc
Recent Activity
8.63%
$104.25M
2.606M shares@ $40.0 avg price
VRNAVerona Pharma Plc
Recent Activity
8.46%
$102.127M
3.55M shares@ $28.78 avg price
SVASinovac Biotech Ltd.
Recent Activity
6.32%
$76.346M
11.8M shares@ $6.47 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
Increased 11.53%
4.76%
$57.511M
6.896M shares@ $8.35 avg price
TILInstil Bio Inc
Recent Activity
3.48%
$42.031M
624,339 shares@ $67.32 avg price
DYNDyne Therapeutics Inc
Recent Activity
Decreased -31.81%
3.32%
$40.049M
1.115M shares@ $35.92 avg price
VRDNViridian Therapeutics Inc
Recent Activity
3.16%
$38.179M
1.678M shares@ $22.75 avg price
AVDLAvadel Pharmaceuticals Plc
Recent Activity
New Position
2.92%
$35.202M
2.684M shares@ $13.12 avg price